Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

GlaxoSmithKline LLC 5 Moore Drive Research Triangle Park NC 27709-0143 USA

UEI: SLED_FE47A4CADBE6EF44

GlaxoSmithKline LLC 5 Moore Drive Research Triangle Park NC 27709-0143 USA is a federal contractor, registered under UEI SLED_FE47A4CADBE6EF44. It has been awarded $8,359,043 in federal contracts. Primary work spans Biological Product (except Diagnostic) Manufacturing.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_FE47A4CADBE6EF44

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

GlaxoSmithKline LLC specializes in the high-scale manufacture and release of pharmaceutical components. Their core capabilities include the production of cGMP commercial-scale bulk lots, with specific technical expertise in the development and delivery of adjuvant systems. The company has experienc...

GlaxoSmithKline LLC specializes in the high-scale manufacture and release of pharmaceutical components. Their core capabilities include the production of cGMP commercial-scale bulk lots, with specific technical expertise in the development and delivery of adjuvant systems. The company has experience supporting the Defense Health Agency within the Department of Defense, providing critical manufacturing services for medical countermeasures. Their industry focus is centered on NAICS 325414, specializing in the production of biological products and pharmaceutical manufacturing.

Key Performance Metrics

Awards Count

1

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
$8.4M100%
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with GlaxoSmithKline LLC 5 Moore Drive Research Triangle Park NC 27709-0143 USA

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for GlaxoSmithKline LLC 5 Moore Drive Research Triangle Park NC 27709-0143 USA

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in GlaxoSmithKline LLC 5 Moore Drive Research Triangle Park NC 27709-0143 USA's top NAICS codes and agencies

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

20 days ago

DEADLINE

in 20 days
View Details
NAICS: 325414
DIBBS
Measles, Mumps, and Rubella (MMR) Vaccine Supply and DeliveryThe contract entails the supply and delivery of three units of Measles, Mumps, and Rubella vaccine to a U.S. Navy vessel at a forward operating base destination, with strict requirements for traceable express shipping and full compliance with established medical handling standards. The contractor is responsible for ensuring the vaccines remain viable throughout transit by adhering to temperature control, packaging, and documentation protocols mandated for biological materials. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, with a NAICS code of 325414 indicating pharmaceutical preparation manufacturing. The delivery must be completed in accordance with military logistics guidelines, and all shipping records must maintain a verifiable chain of custody from origin to final receipt aboard the vessel. The contract was posted on August 9, 2026, and the place of performance is tied to a military operational location, though specific geographic details are not provided. The award reference number SPE2DX25D8022 and delivery identifier SPE2D926F8119 are linked to the official DLA procurement system, underscoring the mission-critical nature of timely and secure delivery. While the solicitation number is not listed, the subcontract structure suggests coordination with a prime contractor to fulfill the DOD’s medical readiness requirements. All activities must comply with federal regulations governing vaccine distribution and military supply chain integrity.
Defense Logistics Agency

POSTED

2 months ago

DEADLINE

N/A
View Details